A systematic review of studies analyzing preoperative chemoradiation of squamous cell carcinoma (SCC) or adenocarcinoma (AC) of the esophagus demonstrated no significant difference in pathologic ...
Of 131 patients evaluated, 14 patients developed the spectrum of SCC/AK within 9.3 months of starting sorafenib (median, 6.5 months; range, 0.9–43 months). The median duration of follow-up for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback